中文 | English
Return
Total: 9 , 1/1
Show Home Prev Next End page: GO
Author:( Yaozu XIANG)

2.Administration and quality control of large-scale clinical trials of traditional Chinese medicine

Hongcai SHANG ; Junhua ZHANG ; Guohua DAI ; Hongbo CAO ; Ming REN ; Yaozu XIANG ; Yang WANG ; Boli ZHANG ; Youping LI

Journal of Integrative Medicine 2007;5(1):1-4

3.Case recruitment in large-scale clinical trials of traditional Chinese medicine

Hongbo CAO ; Hongcai SHANG ; Ming REN ; Junhua ZHANG ; Xin GAO ; Yaozu XIANG ; Guohua DAI ; Yang WANG ; Xiumei GAO ; Boli ZHANG

Journal of Integrative Medicine 2007;5(3):243-6

4.Myocardial infarction secondary prevention study (MISPS)

Hongcai SHANG ; Guohua DAI ; Junhua HANG ; Yaozu XIANG ; Yang WANG ; Junping ZHANG ; Wuxun DU ; Jingyuan MAO ; Chen YAO ; Weiliang WENG ; Tiancai WEN ; Boli ZHANG

Journal of Geriatric Cardiology 2006;3(2):116-119

5.Tracing PRX1+ cells during molar formation and periodontal ligament reconstruction.

Xuyan GONG ; Han ZHANG ; Xiaoqiao XU ; Yunpeng DING ; Xingbo YANG ; Zhiyang CHENG ; Dike TAO ; Congjiao HU ; Yaozu XIANG ; Yao SUN

International Journal of Oral Science 2022;14(1):5-5

6. Utilization of inpatient health care and its influencing factors among elderlies in Shandong province

Lu LU ; Xiang JING ; Yali WANG ; Yu XIA ; Yaozu LI ; An′an JIAO ; Lingzhong XU

Chinese Journal of Hospital Administration 2019;35(11):947-951

7. Willingness for downward referral and its influencing factors among rural elderlies with hospital stay in Shandong province

Xiang JING ; Lu LU ; Yu XIA ; Yali WANG ; Yaozu LI ; An′an JIAO ; Lingzhong XU

Chinese Journal of Hospital Administration 2019;35(11):952-956

8.Cardioprotective mechanism of SGLT2 inhibitor against myocardial infarction is through reduction of autosis.

Kai JIANG ; Yue XU ; Dandan WANG ; Feng CHEN ; Zizhuo TU ; Jie QIAN ; Sheng XU ; Yixiang XU ; John HWA ; Jian LI ; Hongcai SHANG ; Yaozu XIANG

Protein & Cell 2022;13(5):336-359

9.Structural repurposing of SGLT2 inhibitor empagliflozin for strengthening anti-heart failure activity with lower glycosuria.

Yixiang XU ; Chao ZHANG ; Kai JIANG ; Xinchun YANG ; Feng CHEN ; Zhiyang CHENG ; Jinlong ZHAO ; Jiaxing CHENG ; Xiaokang LI ; Xin CHEN ; Luoyifan ZHOU ; Hao DUAN ; Yunyuan HUANG ; Yaozu XIANG ; Jian LI

Acta Pharmaceutica Sinica B 2023;13(4):1671-1685

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 9 , 1/1 Show Home Prev Next End page: GO